Results

Total Results: 316 records

Showing results for "vascular".

81. Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
    March 01, 2009 - harms of aspirin for the primary prevention of CVD events (KQ2), we used the terms aspirin, cardio- vascular … general, we included studies that evaluated aspirin versus control for the primary prevention of cardio- vascular … ours in that we searched for recent studies published since 2001 and we used the broader term cardio- vascular … Aspirin use in women was associated with statistically significant reductions in cardio- vascular events

82. Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/wdxHdZ2U5ggjuNW-nwun8n
    October 01, 2009 - Benchmarks for the assessment of novel cardio- vascular biomarkers [Editorial]. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … White blood cell count and cardio- vascular disease. Insights from the Framingham Study. … Pres- ence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. … Is C-reactive protein specific for vascular disease in women? Ann Intern Med. 2002;136:529-33.

83. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/impaired-visual-acuity-screening-older-adults
    May 24, 2022 - Study Selection: Randomized clinical trials and controlled observational studies on screening, vascular … Treatment focused on benefits and harms of wet AMD (intravitreal vascular endothelial growth factor [ … discontinued because of higher rates of intraocular inflammation, including retinal vasculitis and retinal vascular … Introducing anti-vascular endothelial growth factor therapies for AMD did not raise risk of myocardial … NA, not applicable; OR, odds ratio; RR, risk ratio; USPSTF, US Preventive Services Task Force; VEGF, vascular

84. Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening
    March 01, 2016 - Random-effects meta-analysis was used to estimate the relative and absolute benefits of vascular endothelial … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related … AMD indicates age-related macular degeneration; VEGF, vascular endothelial growth factor. … VEGF indicates vascular endothelial growth factor. Text Description . … VEGF indicates vascular endothelial growth factor. Text Description .

85. Archived: Evidence Summary: Impaired Visual Acuity in Older Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/impaired-visual-acuity-in-older-adults-screening-2016
    March 01, 2016 - Random-effects meta-analysis was used to estimate the relative and absolute benefits of vascular endothelial … Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related … AMD indicates age-related macular degeneration; VEGF, vascular endothelial growth factor. … VEGF indicates vascular endothelial growth factor. Text Description . … VEGF indicates vascular endothelial growth factor. Text Description .

86. Screening Older Adults for Impaired Visual Acuity: A Review of the Evidence for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7eLc5kBtomL_HKpYDwsFPf
    July 01, 2009 - Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … Vascular endothelial growth factor inhibitors were associated with mild to moderate improvements in vision … Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors. … For wet AMD, vascular endothelial growth factor inhibitors and photodynamic therapy with vertepor- fin … Randomized, double-masked, sham-controlled trial of ranibizumab for neo- vascular age-related macular

87. Archived: Final Evidence Summary: Lipid Disorders in Children: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary34/lipid-disorders-in-children-screening-2007
    July 15, 2007 - New vascular markers such as apolipoprotein B and apolipoprotein A-I may prove to be useful for screening … in children. 263 , 264 There is a growing literature on non-invasive vascular outcomes such as carotid … Cholesterol screening and family history of vascular disease. … The relationship between parental history of vascular disease and cardiovascular disease risk factors … Bethesda, MD: National Institutes of Health; Lipid Metabolism Branch; Division of Heart and Vascular

88. Final Research Plan: Cardiovascular Disease Risk: Screening With Electrocardiography | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-risk-screening-with-electrocardiography
    July 14, 2016 - In response to comments, the USPSTF replaced the term “cerebral vascular accident” with “stroke,” “cardioembolic

89. Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/aspirin-to-prevent-cardiovascular-disease-preventive-medication
    April 26, 2022 - Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular … Aspirin for stroke prevention in elderly patients with vascular risk factors: Japanese Primary Prevention … Effect of low-dose aspirin on functional outcome from cerebral vascular events in women. … Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects … Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis

90. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors
    October 15, 2009 - National Cholesterol Education Program algorithm categorizes adults without CHD, diabetes, or noncardiac vascular … , this evidence cannot provide an unbiased determination of how many asymptomatic men without known vascular … Homocysteine lowering with folic acid and B vitamins in vascular disease. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

91. Archived: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2003
    February 04, 2003 - primarily as a late complication related to the development of distal sensory neuropathy and peripheral vascular … (HPS) found that including simvastatin in the treatment regimen of diabetic patients reduces major vascular … infarction, stroke, and revascularization) from 25 percent to 20 percent, i.e., prevents one major vascular … Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular

92. Archived: Coronary Heart Disease: Screening Using Non-Traditional Risk Factors | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/coronary-heart-disease-screening-using-non-traditional-risk-factors-2009
    October 15, 2009 - National Cholesterol Education Program algorithm categorizes adults without CHD, diabetes, or noncardiac vascular … , this evidence cannot provide an unbiased determination of how many asymptomatic men without known vascular … Homocysteine lowering with folic acid and B vitamins in vascular disease. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

93. Fbqmoapkebekmj7Aqmale5 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/fbQmoAPKeBekmJ7aqmALe5
    June 01, 2014 - The major de- mentia syndromes in older adults include Alzheimer dis- ease, vascular dementia, frontotemporal … 60% to 80% of all dementia, frontotemporal dementia accounts for 12% to 25%, 10% to 20% is considered vascular … delaying cognitive impairment (AChEIs and memantine), medications for cardiovascular risk reduction for vascular … causes of dementia was mentioned in a few comments, and information on USPSTF recommendations related to vascular

94. Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
    November 13, 2016 - Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease … Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial … Endstage Disease Intervention Trial; PVD, peripheral vascular disease; SBP, systolic blood pressure;

95. Archived: Evidence Summary: Statins for Prevention of Cardiovascular Disease in Adults: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. … The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease … Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial … Endstage Disease Intervention Trial; PVD, peripheral vascular disease; SBP, systolic blood pressure;

96. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
    September 03, 2013 - The Viborg Vascular screening trial, which is currently under way, is a population-based screening trial … Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular … Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery … Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people … The Viborg Vascular (VIVA) screening trial of 654 year old men in the central region of Denmark: study

97. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
    September 03, 2013 - The Viborg Vascular screening trial, which is currently under way, is a population-based screening trial … Data Standards (Writing Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular … Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery … Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people … The Viborg Vascular (VIVA) screening trial of 654 year old men in the central region of Denmark: study

98. Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/j69Hq5ALvzg74e-ngkzSep
    April 01, 2016 - Effect of aspirin on vascular and nonvascular out- comes: meta-analysis of randomized controlled trials … Short-term effects of daily aspirin on cancer inci- dence, mortality, and non-vascular death: analysis … Aspirin in the pri- mary and secondary prevention of vascular disease: collaborative meta-analysis of … Low-dose aspirin for primary prevention of cardio- vascular events in Japanese patients 60 years or older … Aspirin treatment and risk of first incident cardio- vascular diseases in patients with type 2 diabetes

99. 6Ngc3Byq9Jeby Pwyvd6Or (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/6Ngc3byQ9jeBy_pwyvD6or
    September 01, 2014 - Ultrasonography laboratories; practitioners who found bruits or CAS during evaluation for peripheral vascular … Bertges DJ, Goodney PP, Zhao Y, Schanzer A, Nolan BW, Likosky DS, et al; Vascular Study Group of New … The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more … accurately than the Revised Cardiac Risk Index in vascular surgery patients. … Goodney PP, Likosky DS, Cronenwett JL; Vascular Study Group of Northern New England.

100. Final Research Plan: Hypertension in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertension-in-adults-screening
     October 04, 2018 - In response, the USPSTF added symptomatic peripheral artery disease and vascular dementia as health outcomes